Australia's specialist pharmacy review service for personal injury insurers
Independent & Purpose-built by pharmacists exclusive to personal injury claims
Independent Med Management provides pharmacy reviews and medication management services exclusively to the Australian personal injury insurance sector. We don't dispense or supply medications, and we don't profit from their continued use. Our only role is to provide independent, evidence-based pharmacist opinions that help insurers, treating doctors, and injured people make better medication decisions.
Built for this. Nothing else.
IMM was purpose-built to do one thing: provide independent pharmacist opinions and medication management for personal injury insurance claims. It's not one of many services we offer - it's the only thing we do. That singular focus shapes everything, from how we train our pharmacists to how we engage with treating doctors and deliver reports.
10,000+
medication assessments across WC & CTP
8 days
average report turnaround
2 doctors
engaged per report on average
24 hours
referral triage and action
Independent by design - IMM does not dispense or supply medications. Every recommendation is made without commercial bias.
480 hours of specialist training - Every IMM pharmacist completes 12 weeks of full-time, industry-specific training before working on live claims.
Employed pharmacists, not contractors - Our pharmacists are employed by IMM, with weekly clinical education sessions covering regulatory and clinical changes in the insurance and pharmaceutical landscape.
Approved nationally - Supported by regulators across all Australian states and territories. Trusted by GIO/Suncorp, EML, QBE, Allianz, DXC, Gallagher Bassett and more.
Pharmacy review is all we do - We are not an IME provider, a medico-legal firm, or a dispensing pharmacy offering reviews as a side service. This is our sole focus, and it shows in the depth and quality of every report.
Our Services
Two specialist services designed to support medication-related claims decisions across Workers' Compensation, CTP, and income protection
Independent Pharmacy Reviews
Independent pharmacist opinions on medication appropriateness, risks, and alternatives, giving claims teams the clinical clarity to make confident funding and liability decisions.
Reasons to refer for a pharmacy review:
- Uncertainty about whether prescribed medications are reasonable and necessary for the claim
- Medicinal cannabis requested or approved without clear treatment goals or evidence
- Escalating medication costs without clear clinical benefit or improvement
- Each pharmacist completes over 480 hours of IMM industry-specific training before working on live claims
- Our pharmacists are employed by IMM, not contractors or community pharmacists, ensuring consistency in reports and turnaround timeframes
Medication Management
Ongoing pharmacist-led medication oversight to reduce medication-related risk and liability while supporting better patient outcomes, safer recovery, and return-to-work rates.
Reasons to refer for medication management:
- Medications contributing to delayed recovery, incapacity, or prolonged claim duration
- Polypharmacy causing sedation, cognitive impairment, fatigue, falls, or dependency risk
- Medication risk identified but no management plan or clinical oversight is in place
- Each pharmacist completes over 480 hours of IMM industry-specific training before working on live claims
- Our pharmacists are employed by IMM, not contractors or community pharmacists, ensuring consistency in reports and turnaround timeframes
Why independence matters in pharmacy review
Medication-related risk in personal injury claims doesn't appear overnight. It develops over weeks and months of prescribing, dispensing, and repeat scripts - often involving multiple prescribers, multiple pharmacies, and limited oversight of the full medication picture.
By the time a claim is referred for a pharmacy review, the dispensing pharmacist has already had every opportunity to identify concerns. In many cases it hasn't, because community pharmacies are primarily structured to dispense - not to assess whole-of-medication risk across a complex claim like we are.
The structural gap
When a provider both supplies medications and reviews whether those medications are appropriate, there is an inherent tension. The revenue model is built on dispensing volume. Questioning the appropriateness of a medication is, in effect, questioning the revenue stream.
Similarly, when a pharmacy review is offered as one of many services within a broader medico-legal or IME business, it often lacks the specialist depth required to engage meaningfully with prescribers and drive real change. A pharmacy review added to an IME panel is not the same as a pharmacist whose entire professional focus, training, and clinical support structure is built around medication risk in insurance claims.
IMM's approach
IMM was built without a dispensing arm deliberately. Our pharmacists have no financial relationship with the medications they review. They are not paid to supply, and their recommendations are not influenced by dispensing revenue.
This independence is not a marketing position - it is a structural design choice that ensures every opinion we provide is made solely on the basis of clinical evidence, regulatory guidelines, and the claimant's best interest.
It's also why treating doctors engage with our recommendations. When a pharmacist contacts a prescriber with no commercial interest in the outcome, the conversation is clinical, not adversarial. This is reflected in our 81% prescriber implementation rate - treating doctors act on our recommendations because they trust the independence behind them.
Pharmacists trained for this industry, not just this profession
Pharmacy review in the personal injury insurance sector is fundamentally different from community pharmacy or hospital pharmacy. The clinical context is different. The stakeholders are different. The reporting requirements are different. And the consequences of getting it wrong - for the injured person, the insurer, and the treating doctor - are significant.
That's why every IMM pharmacist goes through an industry-specific training program before they work on a single live claim.
480
hours of dedicated training
12 weeks. Full-time. 40 hours per week. This program was designed and built by IMM from our own industry experience. It covers the clinical, regulatory, and insurance frameworks that pharmacists need to provide meaningful, defensible opinions in the context of Workers' Compensation and CTP claims.
100%
employed, not contracted
IMM pharmacists are employees of the organisation, not independent contractors brought in per-case. This means consistent quality, consistent methodology, and accountability for every report.
Weekly
clinical education
Our pharmacists attend weekly education sessions covering changes in the insurance and clinical landscape - new medications, regulatory updates, emerging risks, and evolving best practice. This isn't annual CPD. It's continuous, structured learning built into how we operate.
No other pharmacy review provider in Australia has built this level of industry-specific clinical infrastructure. It's why our reports are trusted by insurers, acted on by prescribers, and ultimately lead to better outcomes for injured people.
Outcomes that change claims, not just reports
Pharmacy review shouldn't end at a report. The value is in what changes. When high-risk medications are deprescribed or optimised through clinical engagement with treating doctors, the risk itself is resolved - not just identified. That means insurers don't have to decline funding to de-risk the claim. The risk is addressed at the source, creating better outcomes for the injured person and the insurer.
Risk resolved, not just identified
Our 81% prescriber implementation rate means recommendations don't sit in reports - they're acted on. Treating doctors engage because our pharmacists bring clinical independence and specialist expertise to the conversation, not a commercial agenda.
Better recovery, fewer secondary conditions
Reducing inappropriate sedatives, opioids, cannabis, and polypharmacy improves alertness, cognition, and physical function. Injured people can engage more fully in rehabilitation, return to work sooner, and reclaim their quality of life. Medication optimisation reduces medication-induced secondary psychological injury and claims costs.
Defensible decisions, reduced liability
Independent pharmacist input gives insurers a defensible clinical pathway where funding decisions are supported by evidence. Long-tail claim risk is reduced because medication issues are clinically resolved, and prescribers are held liable for residual risk once formally notified.
Industry Insights
Expert perspectives on medication management, prescribing trends, and regulatory developments in the Australian personal injury insurance sector.
Resolve medication risk. Don't just report on it.
Whether you need an independent pharmacy review for a specific claim or want to discuss how structured medication management could support your portfolio, our pharmacists are here to help.
Got Questions? Speak to an Independent Pharmacist
Unbiased advice on your claimant's medications and recovery plan.
